日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer.

整合转录组学和单细胞分析揭示IL27RA是乳腺癌中的关键免疫调节因子和治疗指标

Chen Yi, Anwar Munawar, Wang Xiaoli, Zhang Boxiang, Ma Binlin

Prognostic value of preoperative modified Glasgow prognostic score in predicting overall survival in breast cancer patients: A retrospective cohort study

术前改良格拉斯哥预后评分在预测乳腺癌患者总生存期中的预后价值:一项回顾性队列研究

Chen, Yi; Zhang, Boxiang; Wang, Xiaoli; Chen, Yanyan; Anwar, Munawar; Fan, Jingjing; Ma, Binlin

Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in HER2+ breast cancer: a gene expression-based study

肿瘤突变负荷的预后价值及其与HER2阳性乳腺癌免疫浸润的关系:一项基于基因表达的研究

Wen, Ying; Ouyang, Dengjie; Chen, Qitong; Zeng, Liyun; Luo, Na; He, Hongye; Anwar, Munawar; Qu, Limeng; Zou, Qiongyan; Yi, Wenjun

A literature review of the promising future of TROP2: a potential drug therapy target

TROP2作为潜在药物治疗靶点的前景展望:文献综述

Wen, Ying; Ouyang, Dengjie; Zou, Qiongyan; Chen, Qitong; Luo, Na; He, Hongye; Anwar, Munawar; Yi, Wenjun

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data

吡咯替尼治疗HER2阳性转移性乳腺癌合并脑转移患者:真实世界多中心数据的探索性最终分析

Anwar, Munawar; Chen, Qitong; Ouyang, Dengjie; Wang, Shouman; Xie, Ning; Ouyang, Quchang; Fan, Peizhi; Qian, Liyuan; Chen, Gannong; Zhou, Enxiang; Guo, Lei; Gu, Xiaowen; Ding, Boning; Yang, Xiaohong; Liu, Liping; Deng, Chao; Xiao, Zhi; Li, Jing; Wang, Yunqi; Zeng, Shan; Hu, Jinhui; Zhou, Wei; Qiu, Bo; Wang, Zhongming; Weng, Jie; Liu, Mingwen; Li, Yi; Tang, Tiegang; Wang, Jianguo; Zhang, Hui; Dai, Bin; Tang, Wuping; Wu, Tao; Xiao, Maoliang; Li, Xiantao; Liu, Hailong; Li, Lai; Yi, Wenjun